These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 28554743)

  • 1. Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.
    Zhou L; Rui JA; Zhou WX; Wang SB; Chen SG; Qu Q
    Pathol Res Pract; 2017 Jul; 213(7):824-830. PubMed ID: 28554743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early recurrence in large hepatocellular carcinoma after curative hepatic resection: prognostic significance and risk factors.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Hepatogastroenterology; 2014 Oct; 61(135):2035-41. PubMed ID: 25713907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of recurrence and poor survival in curatively resected hepatocellular carcinoma with microvascular invasion.
    Zhou L; Wang SB; Chen SG; Qu Q; Rui JA
    Adv Clin Exp Med; 2020 Jul; 29(7):887-892. PubMed ID: 32750753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological predictors of poor survival and recurrence after curative resection in hepatocellular carcinoma without portal vein tumor thrombosis.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Pathol Oncol Res; 2015 Jan; 21(1):131-8. PubMed ID: 24908141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection.
    Zhou L; Rui JA; Ye DX; Wang SB; Chen SG; Qu Q
    World J Surg; 2008 Aug; 32(8):1748-56. PubMed ID: 18493820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma.
    Du M; Chen L; Zhao J; Tian F; Zeng H; Tan Y; Sun H; Zhou J; Ji Y
    BMC Cancer; 2014 Jan; 14():38. PubMed ID: 24460749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of tumor markers in patients with recurrent hepatocellular carcinoma in different vascular invasion pattern.
    Gao F; Zhu HK; Zhu YB; Shan QN; Ling Q; Wei XY; Xie HY; Zhou L; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2016 Aug; 15(4):371-7. PubMed ID: 27498576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    J Surg Res; 2010 Mar; 159(1):538-44. PubMed ID: 19111323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
    Hepatobiliary Pancreat Dis Int; 2013 Feb; 12(1):68-73. PubMed ID: 23392801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
    Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
    World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta-slope of alpha-fetoprotein improves the ability to select liver transplant patients with hepatocellular cancer.
    Lai Q; Inostroza M; Rico Juri JM; Goffette P; Lerut J
    HPB (Oxford); 2015 Dec; 17(12):1085-95. PubMed ID: 26373980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predictive for long-term survival of male patients with hepatocellular carcinoma after curative resection.
    Zhou L; Rui JA; Wang SB; Chen SG; Qu Q; Chi TY; Wei X; Han K; Zhang N; Zhao HT
    J Surg Oncol; 2007 Mar; 95(4):298-303. PubMed ID: 17326130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
    Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
    Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
    Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
    Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.